| |
| |
|
| Insider
Information: |
Barbari Sharon Surrey |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
161,755 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,682,668 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,755 |
|
|
| Total
Value |
$2,682,668 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Chief Financial Officer |
2004-04-30 |
2,041 |
2004-04-30 |
0 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
EVP, Finance & CFO |
2017-02-28 |
40,323 |
2009-11-16 |
0 |
Premium* |
|
|
Sonoma Pharmaceuticals Inc |
SNOA |
Director |
2018-03-01 |
43,417 |
2016-02-29 |
0 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
|
2023-06-08 |
974 |
2020-06-09 |
0 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
Director |
2020-08-20 |
75,000 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGRX |
Agile Therapeutics Inc |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
974 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
1,952 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
24,510 |
51,296 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Director |
– • – |
2020-08-20 |
4 |
OE |
$1.48 |
$111,000 |
D/D |
75,000 |
75,000 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
26,786 |
26,786 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,424 |
43,417 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,211 |
41,993 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2017-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
13,944 |
24,782 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2017-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
880 |
10,838 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2017-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
754 |
9,958 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2017-02-28 |
4 |
D |
$10.60 |
$77,560 |
D/D |
(7,317) |
40,323 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$19 |
D/D |
18,750 |
47,640 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2016-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,035 |
6,244 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2016-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,199 |
5,209 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2016-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,445 |
20,051 |
0 |
- |
|
| SNOA |
Sonoma Pharmaceuticals In... |
Director |
– • – |
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,606 |
15,606 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2013-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
31,040 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2013-09-03 |
4 |
D |
$7.65 |
$47,904 |
D/D |
(6,262) |
24,778 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2012-09-04 |
4 |
D |
$0.76 |
$27,832 |
D/D |
(36,631) |
83,746 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2012-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
120,377 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP, Finance & CFO |
• – – |
2009-11-16 |
4 |
OE |
$3.37 |
$6,740 |
D/D |
2,000 |
14,127 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chief Financial Officer |
• – – |
2004-04-30 |
4 |
A |
$12.58 |
$8,554 |
D/D |
680 |
2,041 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
